Glycemic index in chronic disease: A review

European Journal of Clinical Nutrition

Volumn 56, Issue 11, 2002, Pages 1049-1071

  Agustin, L S ^a,b   Franceschi, S ^a,d   Jenkins, J D A ^b,c   Kendall, C W C ^b,c   La Vecchia, C ^e,f  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF TORONTO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

Cancer; Coronary heart disease; Diabetes; Glycemic index; Glycemic load; Obesity

Indexed keywords

CARBOHYDRATE; GLUCOSE; LIPID;

BLOOD GLUCOSE MONITORING; CALORIC INTAKE; CANCER; CARBOHYDRATE ABSORPTION; CARBOHYDRATE INTAKE; CHRONIC DISEASE; DIABETES MELLITUS; DIET THERAPY; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; FOOD ANALYSIS; GASTROINTESTINAL ABSORPTION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; IN VITRO STUDY; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; OBESITY; PHYSICAL ACTIVITY; POSTPRANDIAL STATE; REVIEW; SATIETY;

AREA UNDER CURVE; BLOOD GLUCOSE; CHRONIC DISEASE; DIABETES MELLITUS; DIETARY CARBOHYDRATES; EXERCISE; FOOD; GLYCEMIC INDEX; HEART DISEASES; HUMANS; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; NEOPLASMS; OBESITY; POSTPRANDIAL PERIOD;

ANIMALIA;

EID: 0036857691     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1601454     Document Type: Review

References (339)

1. Aaronson S (1991): Growth factors and cancer. Science 254, 1146-1153.
2. Adami HO, McLaughlin MJ, Ekbom A et al (1991): Cancer risk in patient with diabetes mellitus. Cancer Causes Control 2, 307-314.
3. Akkus I, Kalak S, Vural H, Caglayan O, Menekse E, Can G & Durmus B (1996): Leukocyte lipid peroxidation, superoxide dismutase, glutathione peroxidase and serum and leukocyte vitamin C levels of patients with type II diabetes mellitus. Clin. Chim. Acta 244, 221-227.
4. American Diabetes Association (1994): Position Statement. Nutrition recommendations and principles for people with diabetes mellitus. Diabetes Care 17, 519-522.
5. Andersson SO, Wolk A, Bergstrom R et al (1997): Body size and prostate cancer: a 20-year follow-up among 135006 Swedish construction workers. J. Natl Cancer Inst. 89, 385-389.
6. Arnold LM, Ball MJ, Duncan AQ & Mann J (1993): Effect of isoenergetic intake of three or nine meals on plasma lipoproteins and glucose metabolism. Am. J. Clin. Nutr. 57, 446-451.
7. Astrup A & Raben A (1992): Obesity: an inherited metabolic deficiency in the control of macronutrient balance? Eur. J. Clin. Nutr. 46, 611-620.
8. Augustin LS, Dal Maso L, La Vecchia C, Parpinel M, Negri E, Vaccarella S, Kendall CKW, Jenkins DJA & Franceschi S (2001): Dietary glycemic index and glycemic load in breast cancer risk: a case-control study. Ann. Oncol. 12, 1533-1538.
9. Axelsen M, Lonnroth P, Arvidsson Lenner R & Smith U (1997): Suppression of the nocturnal free fatty acid levels by bedtime cornstarch in NIDDM subjects. Eur. J. Clin. Invest 27, 157-163.
10. Axelsen M, Wesslau C, Lonnroth P, Arvidsson Lenner R & Smith U (1999a): Bedtime uncooked cornstarch supplement prevents nocturnal hypoglycaemia in intensively treated type 1 diabetes subjects. J. Intern. Med. 245, 229-236.
11. Axelsen M, Arvidsson Lenner R, Lonnroth P & Smith U (1999b): Breakfast glycaemic response in patients with type 2 diabetes: effects of bedtime dietary carbohydrates. Eur. J. Clin. Nutr. 53, 706-710.
12. Ballard-Barbash R & Swanson CA (1996): Body weight: estimation of risk for breast and endometrial cancers. Am. J. Clin. Nutr. 63 (Suppl), 437S-441S.
13. Ballard-Barbash R, Schatzkin A, Albanes D et al (1990): Physical activity and risk of large bowel cancer in the Framingham Study. Cancer Res. 50, 3610-3613.
14. Baserga R (1995): The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res. 55, 249-252.
15. Bates P, Fisher R, Ward A, Richardson L, Hill DJ & Graham CF (1995): Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF II). Br. J. Cancer 72, 1189-1193.
16. Bausserman LL, Bernier DN, McAdam KP & Herbert PN (1988): Serum amyloid A and high density lipoproteins during the acute phase response. Eur. J. Clin. Invest. 18, 619-626.
17. Baynes JW (1991): Role of oxidative stress in development of complications in diabetes. Diabetes 40, 405-412.
18. Beaudeux J-L, Guillausseau P-J, Peynet J, Flourie F, Assayag M, Tielmans D, Warnet A & Rousselet F (1995): Enhanced susceptibility of low-density lipoprotein to in vitro oxidation in type 1 and type 2 diabetic patients. Clin. Chim. Acta 239, 131-141.
19. Behall KM, Scholfield DJ & Canary J (1988): Effect of starch structure on glucose and insulin responses in adults. Am. J. Clin. Nutr. 47, 428-432.
20. Benito E, Obrador A, Stiggelbout A et al (1990): A population-based case-control study of colorectal cancer in Majorca I. Dietary factors. Int. J. Cancer 45, 69-76.
21. Benito E, Cabeza E, Moreno V, Obrador A & Bosch FX (1993): Diet and colorectal adenomas: a case-control study in Majorca. Int. J. Cancer 55, 213-219.
22. Berrino F, Bellati C, Secreto G, Camerini E, Pala V, Panico S, Allegro G & Kaaks R (2001): Reducing bioavailable sex hormones through a comprehensive change in diet: the diet and androgens (DIANA) randomized trial. Cancer Epidemiol. Biomarkers Prev. 10, 25-33.
23. Bertelsen J, Christiansen C, Thomsen C et al (1993): Effect of meal frequency on blood glucose, insulin, and free fatty acids in NIDDM subjects. Diabetes Care 16, 4-7.
24. Bhalla V, Joshi K, Vohra H, Singh G & Ganguly NK (2000): Effect of growth factors on proliferation of normal, borderline and malignant breast epithelial cells. Exp. Mol. Pathol. 68, 124-132.
25. Bidoli E, Franceschi S, Talamini R et al (1992): Food consumption and cancer of the colon and rectum in north-eastern Italy. Int. J. Cancer 50, 223-229.
26. Bjork J, Nilsson J, Hultcrantz R & Johansson C (1993): Growth-regulatory effects of sensory neuropeptides, epidermal growth factor, insulin, and somatostatin on the non transformed intestinal epithelial cell line IEC-6 and the colon cancer cell line HT 29. Scand. J. Gastroenterol. 28, 879-884.
27. Boas J (1903): Ueber Carcinom und Diabetes. Berlin Klin. Wschr. 40, 243-247.
28. Boden G, Jadali F, White J, Liang Y, Mozzoli M, Chen X, Coleman E, Smith C (1991): Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. J. Clin. Invest. 88, 960-966.
29. Bohlke K, Cramer DW, Trichopoulos D & Mantzoros CS (1998): Insulin-like growth factor-1 in relation to premenopausal ductal carcinoma in situ of the breast. Epidemiology 9, 570-573.
30. Bornet FRJ, Costagliola D, Rizkalla SW, Blayo A, Fontvieille AM et al (1987): Insulinemic and glycemic indexes of six starch-rich foods taken alone and in a mixed meal by type 2 diabetics. Am. J. Clin. Nutr. 45, 588-595.
31. Bos JL (1998): All in the family? New insights and questions regarding interconnectivity of Ras Rap1 and Ral. EMB0 J. 17, 6776-6782.
32. Bostick RM, Potter JD, Kushi LH et al (1994): Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States). Cancer Causes Control 5, 38-52.
33. Brand JC, Colagiuri S, Crossman S, Allen A, Roberts DC & Truswell AS (1991): Low glycemic index foods improve long term glycemic control in non-insulin-dependent diabetes mellitus. Diabetes Care 14, 95-101.
34. Brand Miller JC (1994): The importance of glycemic index in diabetes. Am. J. Clin. Nutr. 59 (Suppl), 747S-752S.
35. Bristol JB, Emmett PM, Heaton KW & Williamson RC (1985): Sugar, fat, and the risk of colorectal cancer. Br. Med. J. (Clin. Res. Edn) 291, 1467-1470.
36. Bruning PF, Bonfrer JMG, van Noord PAH, Hart AAM, De Jong-Bakker M & Nooijen WJ (1992): Insulin resistance and breast-cancer risk. Int. J. Cancer 52, 511-516.
37. Bruning PF, van Doorn J, Bonfrer JMG, van Noord PAH, Korse CM, Linders TC & Hart AAM (1995): Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer. Int. J. Cancer 62, 266-270.
38. Buchhorn D (1997): Adjusted carbohydrate exchange: Food exchanges for diabetes management corrected with glycemic index. Aust J. Nutr. Dietet. 54, 65-68.
39. Burke BJ, Hartog M, Heaton KW & Hooper S (1982): Assessment of the metabolic effects of dietary carbohydrate and fibre by measuring urinary excretion of C-peptide. Hum. Nutr. Clin. Nutr. 36, 373-380.
40. Buyken AE, Toeller M, Heitkamp G, Karamanos B, Rottiers R, Muggeo M & Fuller JH (2001): Glycemic index in the diet of European outpatients with type 1 diabetes: relations to glycated hemoglobin and serum lipids. Am. J. Clin. Nutr. 73, 574-581.
41. Caderni G, Luceri C, Lancioni L, Giannini A, Fazi M, Brighenti F, Cresci A, Orpianesi C & Dolara P (1997): Modification of azoxymethane intestinal carcinogenesis in rats by feeding sucrose boluses, pasta and glucose. Nutr. Cancer 28, 146-152.
42. Calle-Pascual AL, Gomez V, Leon E & Bordiu E (1988): Foods with a low glycemic index do not improve glycemic control of both type 1 and type 2 diabetic patients after one month of therapy. Diabete Metab. (Paris) 14, 629-633.
43. Calles-Escandon J, Mirza SA, Sobel BE & Schneider DJ (1998): Induction of hyperinsulinemia combined with hyperglycemia and hypertriglyceridemia increases plasminogen activator inhibitor 1 in blood in normal human subjects. Diabetes 47, 290-293.
44. Centonze S, Boeing H, Leoci C, Guerra V & Misciangna G (1994): Dietary habits and colorectal cancer in a low risk area. Results from a population-based case-control study in Southern Italy. Nutr. Cancer 21, 233-246.
45. Ceriello A (2000): Oxidative stress and glycemic regulation. Metabolism 49, 27S-29S.
46. Ceriello A, Bortolotti N, Crescentini A, Motz E, Lizzio S, Russo A, Ezsol Z, Tonutti L & Taboga C (1998a): Antioxidant defences are reduced during the oral glucose tolerance test in normal and noninsulin-dependent diabetic subjects. Eur. J. Clin. Invest. 28, 529-533.
47. Ceriello A, Bortolotti N, Motz E, Crescentini A, Lizzio S, Russo A, Tonutti L & Taboga C (1998b): Meal-generated oxidative stress in type 2 diabetic patients. Diabetes Care 21, 1529-1533.
48. Ceriello A, Bortolotti N, Motz E, Pieri C, Marra M, Tonutti L, Lizzio S, Feletto F, Catone B & Taboga C (1999): Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: the possible role of hyperglycemia. Metabolism 48, 1503-1508.
49. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P et al (1998): Plasma insulin-like growth factor-1 and prostate cancer risk: a prospective study. Science 279, 563-566.
50. Chew I, Brand JC, Thorburn AW & Truswell AS (1985): Plasma glucose and insulin resonses to mixed meals. Proc. Nutr. Soc. Aust. 10, 194.
51. Clarkson P, Celermajer DS, Donald AE, Sampson M, Sorensen KE, Adams M, Yue DK, Betteridge DJ & Deanfield JE (1996): Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. J. Am. Coll. Cardiol. 28, 573-579.
52. Cohen P, Peehl DM, Lamson G & Rosenfeld RG (1991): Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells. J. Clin. Endocrinol. Metab. 73, 401-407.
53. Cohn C (1964): Feeding patterns and some aspects of cholesterol metabolism. Fed. Proc. 23, 76-81.
54. Collett-Solberg PF & Cohen P (1996): The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulation IGF action. Endocrinol. Metab. Clin. N. Am. 25, 591-614.
55. Collier GR, Wolever TMS, Wong GS & Josse RG (1986): Prediction of glycemic response to mixed meals in noninsulin-dependent diabetic subjects. Am. J. Clin. Nutr. 44, 349-352.
56. Collier GR, Giudici S, Kalmusky J et al (1988): Low glycaemic index starchy foods improve glucose control and lower serum cholesterol in diabetic children. Diab. Nutr. Metab. 1, 11-19.
57. Collins P, Williams C & MacDonald I (1981): Effect of cooking on serum glucose and insulin responses to starch. Br. Med. J. 282, 1032-1033.
58. Cominacini L, Garbin U, Pastorino AM, Fratta Pasini A, Campagnola M, De Santis A, Davoli A & Lo Cascio V (1994): Increased susceptibility of LDL to in vitro oxidation in patients with insulin-dependent and non-insulin-dependent diabetes mellitus. Diabetes Res. 26, 173-184.
59. Corpet DE, Peiffer G & Tache S (1998): Glycemic index, nutrient density, and promotion of aberrant crypt foci in rat colon. Nutr. Cancer 32, 29-36.
60. Cosentino F, Hishikawa K, Katusic ZS & Luscher TF (1997): High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96, 25-28.
61. Coulston AM, Hollenbeck CB, Swislolocki MD & Reaven GM (1987): Effect of source of dietary carbohydrate on plasma glucose and insulin responses to mixed meals in subjects with NIDDM. Diabetes Care 10, 395-400.
62. Coulston AM, Hollenbeck CB, Swislolocki MD & Reaven GM (1989): Persistence of hypertriacylglycerolemic effect of low-fat high-carbohydrate diets in NIDDM patients. Diabetes Care 12, 94-101.
63. Coutinho M, Gerstein HC, Wang Y & Yusuf S (1999): The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4y. Diabetes Care 22, 233-240.
64. Del Giudice ME, Fantus IG, Ezzat S, McKeown-Eyssen G, Page D & Goodwin PJ (1998): Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res. Treat. 47, 111-120.
65. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S & Lupien PJ (1996): Hyperinsulinemia as an independent risk factor for ischemic heart disease. New Engl. J. Med. 334, 952-957.
66. de Waard F & Baanders-van Halewijn EA (1974): A prospective study in general practice on breast-cancer risk in postmenopausal women. Int. J. Cancer 14, 153-160.
67. Ducimetiere P, Eschwege E, Papoz L, Richard JL, Claude JR & Rosselin G (1980): Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 19, 205-210.
68. Edelstein SL, Barrett-Connor EL, Wingard DL & Cohn BA (1992): Increased meal frequency associated with decreased cholesterol concentrations; Rancho Bernardo, CA, 1984-1987. Am. J. Clin. Nutr. 55, 664-669.
69. Ellinger F & Landsman H (1944): Frequency and course of cancer in diabetics. NY State J. Med. 44, 259-265.
70. Ellis PR, Dawoud FM & Morris ER (1991): Blood glucose, plasma insulin and sensory responses to guar-containing wheat breads: effects of molecular weight and particle size of guar gum. Br. J. Nutr. 66, 363-379.
71. Englyst KN, Englyst HN, Hudson GJ, Cole TJ & Cummings JH (1999): Rapidly available glucose in foods: an in vitro measurement that reflects the glycemic response. Am. J. Clin. Nutr. 69, 448-454.
72. European Association for the Study of Diabetes (1995): Recomendations for the nutritional management of patients with diabetes mellitus. Diab. Nutr. Metab. 8, 186-189.
73. Ewertz M & Gill C (1990): Dietary factors and breast cancer risk in Denmark. Int. J. Cancer 46, 779-784.
74. FAO/WHO Expert Report. Carbohydrates in human nutrition. Report of a Joint FAO/WHO Expert Consultation, Rome, 14-18 April, 1997. FAO Food and Nutrition Paper 66. Rome, 1998.
75. FAO/WHO Report (1998). Carbohydrate in human nutrition. Report of a Joint FAO/WHO Expert Consultation. FAO Food Nutr. Pap. 66 1-140.
76. Favero A, Salvini S, Russo A, Parpinel M, Negri E, Decarli A, La Vecchia C, Giacosa A & Franceschi S (1997): Sources of macro- and micronutrients in Italian women: results from a food frequency questionnaire for cancer studies. Eur. J. Cancer Prev. 6, 277-287.
77. Favero A, Parpinel M & Franceschi S (1998): Diet and risk of breast cancer: major findings from an Italian case-control study. Biomed. Pharmacother. 52, 109-115.
78. Foekens JA, Portengen H, Janssen M & Klijn JGM (1989): Insulin-like growth factor-1 receptors and insulin-like growth factor 1 like activity in human primary breast cancer. Cancer 63, 2139-2147.
79. Folsom AR, Kaye SA, Princeas RJ, Potter JD, Gapstur SM & Wallace RC (1990): Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women. Am. J. Epidemiol. 131, 794-803.
80. Folsom AR, Kushi LH, Anderson KE, Mink PJ, Olson JE, Hong CP, Sellers TA, Lazovich D & Prineas RJ (2000): Associations of general and abdominal obesity with multiple health outcomes in older women: the Iowa Women's Health Study. Arch. Intern. Med. 160, 2117-2128.
81. Fontvieille AM, Acosta M, Rizkalla SW et al (1988): A moderate switch from high to low glycaemic-index foods for 3 weeks improves the metabolic control of type I (IDDM) diabetic subjects. Diab. Nutr. Metab. 1, 139-143.
82. Fontvieille AM, Rizkalla SW, Penformis A, Acosta M, Bornet FRJ & Slama G (1992): The use of low glycaemic index foods improves metabolic control of diabetic patients over five weeks. Diabet. Med. 9, 444-450.
83. Ford ES & Liu S (2001): Glycemic index and serum high-density lipoprotein cholesterol concentration among US adults. Arch. Intern. Med. 161, 572-576.
84. Foster-Powell K & Brand Miller J (1995): International tables of glycemic index. Am. J. Clin. Nutr. 62, 871S-893S.
85. Franceschi S (1994): Fat and prostate cancer. Epidemiology 5, 271-273.
86. Franceschi S, Favero A, La Vecchia C et al (1995): Influence of food groups and food diversity on breast cancer risk in Italy. Int. J. Cancer 63, 785-789.
87. Franceschi S, Favero A, Decarli A, Negri E, La Vecchia C, Ferraroni M, Russo A, Salvini S, Amadori D, Conti E, Montella M & Giacosa A (1996): Intake of macronutrients and risk of breast cancer. Lancet 347, 1351-1356.
88. Francheschi S, Favero A, La Vecchia C, Negri E, Conti E, Montella M, Giacosa A, Nanni O & Decarli A (1997): Food groups and risk of colorectal cancer in Italy. Int. J. Cancer 72, 56-61.
89. Franceschi S, La Vecchia C, Russo A, Favero A, Negri E, Conti E, Montella M, Filiberti R, Amadori D & Decarli A (1998): Macronutrient intake and risk of colorectal cancer in Italy. Int. J. Cancer 76, 321-324.
90. Franceschi S, Dal Maso L, Augustin L, Negri E, Parpinel M, Boyle P, Jenkins DJ & La Vecchia C (2001): Dietary glycemic load and colorectal cancer risk. Ann. Oncol. 12, 173-178.
91. Freund E (1885): Zur Diagnose des Carcinoms. Wien Med. Blat. 8, 268-269.
92. Frost G, Wilding J & Beecham J (1994): Dietary advice based on the glycaemic index improves dietary profile and metabolic control in type 2 diabetic patients. Diabet. Med. 11, 397-401.
93. Frost G, Keogh B, Smith D, Akinsanya K & Leeds A (1996): The effect of low-glycemic carbohydrate on insulin and glucose response in vivo and in vitro in patients with coronary heart disease. Metabolism 45, 669-672.
94. Frost GS, Keogh BE, Smith D, Leeds AR, Dornhorst A (1998): Reduced adipocyte insulin sensitivity in Caucasian and Asian subjects with coronary heart disease. Diabet. Med. 15, 1003-1009.
95. Frost G, Leeds AA, Dore' CJ, Madeiros S, Brading S & Dornhorst A (1999): Glycaemic index as a determinant of serum HDL-cholesterol concentration. Lancet 353, 1045-1048.
96. Galanis DJ, Kolonel LN, Lee J et al (1998): Anthropometric predictors of breast cancer incidence and survival in a multi-ethnic cohort of female residents of Hawaii. United States. Cancer Causes Control 9, 217-224.
97. Gann PH, Daviglus ML, Dyer AR & Stamler J (1995): Heart rate and prostate cancer mortality: results of a prospective analysis. Cancer Epidemiol. Biomarkers Prev. 4, 611-616.
98. Gannon MC, Nuttall FQ, Neil BJ & Westphal SA (1988): The insulin and glucose responses to meals of glucose plus various proteins in type II diabetic subjects. Metabolism 37, 1081-1088.
99. Garg A, Bantle JP, Henry RR, Coulston AM, Griver KA, Raatz SK, Brinkley L, Chen YD, Grundy SM, Huet BA et al (1994): Effects of varying carbohydrate content of diet in patients with non-insulin-dependent diabetes mellitus. JAMA 271, 1421-1428.
100. Gerstein HC & Yusuf S (1996): Dysglycaemia and risk of cardiovascular disease. Lancet 347, 949-950.
101. Giacco R, Parillo M, Rivellese AA, Lasorella G, Giacco A, D'Episcopo L & Riccardi G (2000): Long-term dietary treatment with increased amounts of fiber-rich low-glycemic index natural foods improves blood glucose control and reduces the number of hypoglycemic events in type 1 diabetic patients. Diabetes Care 23, 1461-1466.
102. Gilbertson HR, Brand-Miller JC, Thorburn AW, Evans S, Chondros P & Werther GA (2001): The effect of flexible low glycemic index dietary advice versus measured carbohydrate exchange diets on glycemic control in children with type 1 diabetes. Diabetes Care 24, 1137-1143.
103. Giovannucci E (1995): Insulin and colon cancer. Cancer Causes Control 6, 164-179.
104. Giovannucci E (1999): Insulin-like growth factor-1 and binding protein-3 and risk of cancer. Horm. Res. 51 (Suppl 3), 34-41.
105. Giovannucci E, Stampfer MJ, Colditz G, Rimm EB & Willett WC (1992): Relationship of diet to risk of colorectal adenoma in men. J. Natl Cancer Inst. 84, 91-98.
106. Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ & Willett WC (1995): Physical activity, obesity, and risk for colon cancer and adenoma in men. Ann. Inern. Med. 122, 327-334.
107. Giovannucci E, Rimm EB, Stampfer MJ et al (1997): Height, body weight, and risk of prostate cancer. Cancer Epidemiol. Biomarkers Prev. 6, 557-663.
108. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA & Willett WC (1998): Diabetes mellitus and risk of prostate cancer (United States). Cancer Causes Control 9, 3-9.
109. Giovannucci E, Pollak MN, Platz EA, Willett WC, Stampfer MJ, Majeed N, Colditz GA, Speizer FE & Hankinson SE (2000): A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol. Biomarkers Prev. 9, 345-349.
110. Golay A & Bobbioni E (1997): The role of dietary fat in obesity. Int. J. Obes. Relat. Metab. Disord. 21, S2-S11.
111. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR Jr, Bangdiwala S & Tyroler HA (1989). High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79, 8-15.
112. 2+/EDRF signaling are due to generation of superoxide anions. Diabetes 45, 1386-1395.
113. Green A & Jensen OM (1985): Frequency of cancer among insulin-treated diabetic patients in Denmark. Diabetologia 28, 128-130.
114. Haber GB, Heaton KW, Murphy D & Burroughs LF (1977): Depletion and disruption of dietary fibre. Effects on satiety, plasma-glucose, and serum-insulin. Lancet 2, 679-682.
115. Hadsell DL, Greenberg NM, Fligger JM, Baumrucker CR & Rosen JM (1996): Targeted expression of des (1-3) human insulin-like growth factor I in transgenic mice influences mammary gland development and IGF-binding protein expression. Endocrinology 137, 321-330.
116. Haenszel W, Locke FB & Segi M (1980): A case-control study of large bowel cancer in Japan. J. Natl Cancer Inst. 64, 17-22.
117. Hankinson S, Pollak M, Michaud D, Willett W, Speizer F, the Nurses' Health Study Research Group (1997): A prospective assessment of plasma insulin-like growth factor levels and breast cancer risk. Am. J. Epidemiol. 145, S72.
118. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE & Pollak M (1998): Circulating concentrations of insulin-like growth factor-1 and risk of breast cancer. Lancet 351, 1393-1396.
119. Hardardottir I, Grunfeld C & Feingold KR (1994). Effects of endotoxin and cytokines on lipid metabolism. Curr. Opin. Lipidol. 5, 207-215.
120. Hardell L, Fredrikson M & Axelson O (1996): Case-control study on colon cancer regarding previous disease and drug intake. Int. J. Oncol. 8, 439-444.
121. Hebert PR, Ajani U, Cook NR, Lee I-M, Chan KS & Hennekens CH (1997): Adult height and incidence of cancer in male physicians (United States). Cancer Causes Control 8, 591-597.
122. Heilbronn LK, Noakes M & Clifton PM (1999): Effect of energy restriction, weight loss, and diet composition on plasma lipids and glucose in patients with type 2 diabetes. Diabetes Care 22, 889-895.
123. Helle SI & Lonning PE (1996): Insulin-like growth factors in breast cancer. Acta Oncol. 35 (Suppl 5), 19-22.
124. Ho GH, Ji CY, Phang BH, Lee KO, Soo KC & Ng EH (1998): Tamoxifen alters levels of serum insulin-like growth factors and binding proteins in postmenopausal breast cancer patients: a prospective paired cohort study. Ann. Surg. Oncol. 5, 361-367.
125. Hoff G, Moen IE, Trygg K et al (1986): Epidemiology of polyps in the rectum and sigmoid colon. Evaluation of nutritional factors. Scand. J. Gastroenterol. 21, 199-204.
126. Hokanson JE & Austin MA (1996). Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J. Cardiovasc. Risk. 3, 213-219.
127. Holt SH & Miller JB (1994): Particle size, satiety and the glycaemic response. Eur. J. Clin. Nutr. 48, 496-502.
128. Holt S, Brand J, Soveny C & Hansky J (1992): Relationship of satiety to postprandial glycaemic, insulin and cholecystokinin responses. Appetite 18, 129-141.
129. Hu FB, Manson JE, Liu S, Hunter D, Colditz GA, Michels KB, Speizer FE & Giovannucci E (1999): Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J. Natl Cancer Inst. 91, 542-547.
130. Huff KK, Kaufman D, Gabbay KH, Spencer EM, Lippman ME & Dickson RB (1986): Secretion of an insulin-like growth factor-1-related protein by human breast cancer cells. Cancer Res. 46, 4613-4619.
131. Hunter DJ & Willett WC (1993): Diet, body size and breast cancer. Epidemiol. Rev. 15, 110-132.
132. Hyka N, Dayer JM, Modoux C, Kohno T, Edwards CK III, Roux-Lombard P & Burger D (2001): Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes. Blood 97, 2381-2389.
133. Illman RJ, Topping DL, McIntosh GH, Trimble RP, Storer GB, Taylor MN & Cheng BQ (1988): Hypocholesterolemic effects of dietary propionate: studies in whole animals and perfused rat liver. Ann. Nutr. Metab. 32, 95-107.
134. Ingram DM, Nottage E & Roberts T (1991): The role of diet in the development of breast cancer: a case-control study of patients with breast cancer, benign epithelial hyperplasia and fibrocystic disease of the breast. Br. J. Cancer 64, 187-191.
135. Iscovich JM, Iscovich RB, Howe J et al (1989): A case-control study of diet and breast cancer in Argentina. Int. J. Cancer 44, 770-777.
136. Jarvi AE, Karlstrom BE, Granfeldt YE, Bjorck IE, Asp NG & Vessby BO (1999): Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients. Diabetes Care 22, 10-18.
137. Jenkins AJ, Dlein RL, Chassereau CN, Hermayer KL & Lopes-Virella MF (1996): LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation. Diabetes 45, 762-767.
138. Jenkins DJA, Wolever TMS, Leeds AR et al (1978): Dietary fibers, fiber analogues, and glucose tolerance: importance of viscosity. Br. Med. J. 1, 1392-1394.
139. Jenkins DJA, Wolever TMS, Taylor RH et al (1981): Glycemic index of foods: a physiological basis for carbohydrate exchange. Am. J. Clin. Nutr. 34, 362-366.
140. Jenkins DJA, Wolever TMS, Jenkins AL, Josse RG & Wong GS (1984): The glycemic response to carbohydrate foods. Lancet 2, 388-391.
141. Jenkins DJA, Thorne MJ, Wolever TMS, Jenkins AL, Rao AV & Thompson LU (1987a): The effect of starch-protein interaction in wheat on the glycemic response and rate of in vitro digestion. Am. J. Clin. Nutr. 45, 946-951.
142. Jenkins DJA, Wolever TMS, Collier GR et al (1987b): Metabolic effects of a low-glycemic-index diet. Am. J. Clin. Nutr. 46, 968-975.
143. Jenkins DJA, Wolever TMS, Kalmusky J, Giudici S, Giordano C, Patten R, Wong GS et al (1987c): Low-glycemic index diet in hyperlipidemia: use of traditional starchy foods. Am. J. Clin. Nutr. 46, 66-71.
144. Jenkins DJA, Wesson V, Wolever TMS et al (1988a): Wholemeal versus wholegrain breads: proportion of whole or cracked grain and the glycaemic response. Br. Med. J. 297, 958-960.
145. Jenkins DJA, Wolever TMS, Buckley G et al (1988b): Low glycemic index starchy foods in the diabetic diet. Am. J. Clin. Nutr. 48, 248-254.
146. Jenkins DJA, Wolever TMS, Vuksan V et al (1989): Nibbling versus gorging: metabolic advantages of increased meal frequency. New Engl. J. Med. 321, 929-934.
147. Jenkins DJ, Wolever TM, Ocana AM, Vuksan V, Cunnane SC, Jenkins M, Wong GS, Singer W, Bloom SR, Blendis LM et al (1990): Metabolic effects of reducing rate of glucose ingestion by single bolus versus continuous sipping. Diabetes 39, 775-781.
148. Jenkins DJA, Ocana A, Jenkins AL et al (1992): Metabolic advantages of spreading the nutrient load: effects of meal frequency in non-insulin-dependent diabetes. Am. J. Clin. Nutr. 55, 461-467.
149. Jenkins DJA, Wolever TMS, Rao AV, Hegele RA, Mitchell SJ, Ransom TPP, Boctor DL et al (1993): Effect on blood lipids of very high intakes of fiber in diets low in saturated fat and cholesterol. New Engl. J. Med. 329, 21-26.
150. Jenkins DJA, Khan A, Jenkins AL et al (1995): Effect of nibbling versus gorging on cardiovascular risk factors: serum uric acid and blood lipids. Metabolism 44, 549-555.
151. Jenkins DJ & Jenkins AL (1995): Nutrition principles and diabetes. A role for "lente carbohydrate"? Diabetes Care 18, 1491-1498.
152. Jenkins DJ, Axelsen M, Kendall CWC, Augustin LSA, Vuksan V & Smith U (2000): Dietary fiber, lente carbohydrates and the insulin resistant diseases. Br. J. Nutr. 83, S157-S163.
153. Jones JI & Clemmons DR (1995): Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16, 3-34.
154. Jones PJ, Leitch CA & Pederson RA (1993): Meal frequency effects of plasma hormone concentrations and cholesterol synthesis in humans. Am. J. Clin. Nutr. 57, 868-874.
155. Juhan-Vague I, Alessi MC, Joly P et al (1989): Plasma plasminogen activator inhibitor-1 in angina pectoris: influence of plasma insulin and acute-phase response. Arteriosclerosis 9, 362-367.
156. Kaaks R (1996): Nutrition, hormones, and breast cancer: is insulin the missing link? Cancer Causes Control 7, 605-625.
157. Kaaks R, Van Noord PA, DenTonkelaar I et al (1998): Breast cancer incidence in relation to height, body-fat distribution in the Dutch 'DOM' cohort. Int. J. Cancer 76, 647-651.
158. Kaklamani VG, Linos A, Kaklamani E, Markaki I, Koumantaki Y, Mantzoros CS (1999): Dietary fat and carbohydrates are independently associated with circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 concentrations in healthy adults. J. Clin. Oncol. 17, 3291-3298.
159. Kanety H, Madjar Y, Dagan Y, Levi J, Papa MZ, Pariente C et al (1993): Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen. J. Clin. Endocrinol. Metab. 77, 229-233.
160. Katsouyanni K, Willett W, Trichopoulos D, Boyle P, Trichopoulou A, Vasilaros S, Papadiamantis J & MacMahon B (1988): Risk of breast cancer among Greek women in relation to nutrient intake. Cancer 61, 181-185.
161. Katsouyanni K, Trichopoulou A, Stuver S, Garas Y, Kritselis A, Kyriakou G, Stoikidou M, Boyle P & Trichopoulos D (1994): The association of fat and other macronutrients with breast cancer: a case-control study from Greece. Br. J. Cancer 70, 537-541.
162. Katsuki A, Sumida Y, Murashima S, Fujii M, Ito K et al (1996): Acute and chronic regulation of serum sex hormone-binding globulin levels by plasma insulin concentrations in male non-insulin-dependent diabetes mellitus patients. J. Clin. Endocrinol. Metab. 81, 2515-2519.
163. Kawano H, Motoyama T, Hirashima O, Hirai N, Miyao Y, Sakamoto T, Kugiyama K, Ogawa H & Yasue H (1999): Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J. Am. Coll. Cardiol. 34, 146-154.
164. Kelloff GJ, Crowell JA, Steele VE, Lubet RA, Boone CW, Malone WA, Hawk ET, Lieberman R, Lawrence JA, Kopelovich L, Ali I, Viner JL & Sigman CC (1999): Progress in cancer chemoprevention. Ann. NY Acad. Sci. 889, 1-13.
165. Kessler II (1970): Cancer mortality among diabetics. J. Natl Cancer Inst. 44, 673-686.
166. Kimura G, Kasuya J, Giannini S, Honda Y, Mohan S, Kawachi M et al (1996): Insulin-like growth factor (IGF) system components in human prostate cancer cell-lines: LNCaP, DU145, and PC-3 cells. Int. J. Urol. 3, 39-46.
167. Koenuma M, Yamori T & Tsuruo T (1989): Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26. Jpn. J. Cancer Res. 80, 51-58.
168. Kono S, Honjo S, Todoroki I, Nishiwaki M, Hamada H, Nishikawa H, Koga H, Ogawa S & Nakagawa K (1998): Glucose intolerance and adenomas of the sigmoid colon in Japanese men (Japan). Cancer Causes Control 9, 441-446.
169. Koska J, Syrova D, Blazicek P, Marko M, Grna DJ, Kvetnansky R & Vigas M (1997): Activity of antioxidant enzymes during hyperglycemia. and hypoglycemia in healthy subjects. Ann. NY Acad. Sci. 82, 575-579.
170. Kritchevsky D & Story JA (1974): Binding of bile salts in vitro by nonnutritive fiber. J. Nutr. 104, 458-462.
171. Kuczmarski RJ, Flegal KM, Campbell SM & Johnson CL (1994): Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 20, 205-211.
172. Kune GA, Kune S & Watson LF (1988): Colorectal cancer risk, chronic illnesses, operations and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res. 48, 4399-4404.
173. Lafrance L, Rabasa-Lhoret R, Poisson D, Ducros F & Chiasson JL (1998): Effects of different glycaemic index foods and dietary fibre intake on glycaemic control in type 1 diabetic patients on intensive insulin therapy. Diabet Med. 15, 972-978.
174. Lahm H, Suardet L, Laurent PL et al (1992): Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor alpha. Br. J. Cancer 65, 341-346.
175. Lakka HM, Lakka TA, Tuomilehto J, Sivenius J & Salonen JT (2000): Hyperinsulinemia and the risk of cardiovascular death and acute coronary and cerebrovascular events in men. Arch. Intern. Med. 160, 1160-1168.
176. La Vecchia C, Negri E, Decarli A et al (1988): A case-control study of diet and colorectal cancer in Northern Italy. Int. J. Cancer 41, 492-498.
177. La Vecchia C, D'Avanzo B, Negri E & Franceschi S (1991): History of selected diseases and the risk of colorectal cancer. Eur. J. Cancer 27, 582-586.
178. La Vecchia C, Franceschi S, Dolora P & Bidoli E (1993): Refined sugar intake and the risk of colorectal cancer in humans. Int. J. Cancer 55, 386-389.
179. La Vecchia C, Negri E, Franceschi S, D'Avanzo B & Boyle P (1994): A case-control study of diabetes mellitus and cancer risk. Br. J. Cancer 70, 950-953.
180. La Vecchia C, Negri E, Decarli A & Franceschi S (1997): Diabetes mellitus and colorectal cancer risk. Cancer Epidemiol. Biomarkers Prev. 6, 1007-1010.
181. Leathwood P & Pollet P (1988): Effects of slow release carbohydrates in the form of bean flakes on the evolution of hunger and satiety in man. Appetite 10, 1-11.
182. Le Floch JP, Baudin E, Escuyer P, Wirquin E, Yomtov B & Perlemuter L (1991): Reproducibility of glucose and insulin responses to mixed meal in type II diabetic patients. Diabetes Care 14, 138-140.
183. Le Marchand L, Wilkens LR, Kolonel LN et al (1997): Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. Cancer Res. 57, 4787-4794.
184. Lenfant C & Ernst N (1994): Daily dietary fat and total food-energy intakes-Third National Health and Nutrition Examination Survey, Phase 1, 1988-1991. Morbid. Mortal. Weekly Rep. 43, 116-117.
185. Levi F, La Vecchia C, Gulie C et al (1993): Dietary factors and breast cancer risk in Vaud, Switzerland. Nutr. Cancer 19, 327-335.
186. Levine GN, Frei B, Koulouris SN, Gerhard MD, Keaney JF Jr & Vita JA (1996): Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 93, 1107-1113.
187. Levine W, Dyer AR, Shekelle RB, Schoenberger JA & Stamler J (1990): Post-load plasma glucose and cancer mortality in middle-aged men and women. 12-year follow-up findings of the Chicago Heart Association Detection Project in Industry. Am. J. Epidemiol. 131, 254-262.
188. Li BD, Khosravi MJ, Berkel HJ, Diamandi A, Dayton MA, Smith M & Yu H (2001): Free insulin-like growth factor-1 and breast cancer risk. Int. J. Cancer 91, 736-739.
189. Liljeberg HG, Akerberg AK & Bjorck IM (1999): Effect of the glycemic index and content of indigestible carbohydrates of cereal-based breakfast meals on glucose tolerance at lunch in healthy subjects. Am. J. Clin. Nutr. 69, 647-655.
190. Liu S, Willett WC, Stampfer MJ, Hu FB, Franz M, Sampson L, Hennekens CH & Manson JE (2000): A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. Am. J. Clin. Nutr. 71, 1455-1461.
191. Lotufo PA, Gaziano JM, Chae CU, Ajani UA, Moreno-John G, Buring JE & Manson JE (2001): Diabetes and all-cause and coronary heart disease mortality among US male physicians. Arch. Intern. Med. 161, 242-247.
192. Ludwig DS, Majzoub JA, Al-Zahrani A, Dallal GE, Blanco I & Roberts SB (1999): High glycemic index foods, overeating, and obesity. Pediatrics 103, E26.
193. Lund Nilsen TI & Vatten LJ (2001): Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinemia hypothesis. Br. J. Cancer 84, 417-422.
194. Luscombe ND, Noakes M & Clifton PM (1999): Diets high and low in glycemic index versus high monounsaturated fat diets: effects on glucose and lipid metabolism in NIDDM. Eur. J. Clin. Nutr. 53, 473-478.
195. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH & Stampfer MJ (1999): Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J. Natl Cancer Inst. 91, 620-625.
196. Macquart-Moulin G, Riboli E, Cornee J et al (1986): Case-control study on colorectal cancer and diet in Marseilles. Int. J. Cancer 38, 183-191.
197. Macquart-Moulin G, Riboli E, Cornee J, Charnay B, Berthezene P & Day N (1987): Colorectal polyps and diet: a case-control study in Marseille. Int. J. Cancer 40, 179-188.
198. Madigan MP, Troisi R, Potischman N et al (1998): Serum hormone levels in relation to reproductive and lifestyle factors in post-menopausal women (United States). Cancer Causes Control 9, 199-207.
199. Malle E, Steinmetz A & Raynes JG (1993). Serum amyloid A (SAA): an acute phase protein and apolipoprotein. Atherosclerosis 102, 131-146.
200. Manjer J, Kaaks R, Riboli E & Berglund G (2001): Risk of breast cancer in relation to anthropometry, blood pressure, blood lipids and glucose metabolism: a prospective study within the Malmo Preventive Project. Eur. J. Cancer. Prev. 10, 33-42.
201. Manousos O, Day NE, Trichopoulos D, Gerovassilis F, Tzonou A & Polychronopoulou A (1983): Diet and colorectal cancer: a case-control study in Greece. Int. J. Cancer 32, 1-5.
202. Manousos O, Souglakos J, Bosetti C et al (1999): IGF-1 and IGF-1I in relation to colorectal cancer. Int. J. Cancer 83, 15-17.
203. Mantzoros CS, Tzonou A, Signorello LB, Stampfer M, Trichopoulos D & Adami HO (1997): Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. Br. J. Cancer 76, 1115-1118.
204. Marble A (1934): Diabetes and cancer. New Engl. J. Med. 211, 339-349.
205. Maxwell SR, Thomason H, Sandler D, Leguen C, Baxter MA, Thorpe GH, Jones AF & Barnett AH (1997): Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. Eur. J. Clin. Invest. 27, 484-490.
206. McKeown-Eyssen G (1994): Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol. Biomarkers Prev. 3, 687-695.
207. Meigs JB, Mittleman MA, Nathan DM, Tofler GH, Singer DE, Murphy-Sheehy PM, Lipinska I, D'Agostino RB & Wilson PW (2000): Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAMA 283, 221-228.
208. Mensink RP & Katan MB (1987): Effect of monounsaturated fatty acids versus complex carbohydrates on high-density lipoproteins in healthy men and women. Lancet 1, 122-125.
209. Meyer KA, Kushi LH, Jacobs DR, Slavin J, Sellers TA & Folsom AR (2000): Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am. J. Clin. Nutr. 71, 921-930.
210. Miglietta L, Barreca A, Repetto L, Costantini M, Rosso R & Boccardo F (1993): Suramin and serum insulin-like growth factor levels in metastatic cancer patients. Anticancer Res. 13, 2473-2476.
211. Miller AB, Howe GR, Jain M, Craib KJ & Harrison L (1983): Food items and food groups as risk factors in a case-control study of diet and colorectal cancer. Int. J. Cancer 32, 155-161.
212. Muck BR, Trotnow S & Hommel G (1975): Cancer of the breast, diabetes and pathological glucose tolerance. Arch. Gynak. 220, 73-81.
213. Must A, Spadano J, Coakley EH, Field AE, Colditz G & Dietz WH (1999): The disease burden associated with overweight and obesity. JAMA 282, 1523-1529.
214. Nabarro JD (1987): Acromegaly. Clin. Endocrinol. (Oxf). 26, 481-512.
215. Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS, Clore JN & Blackard WG (1991): A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 72, 83-89.
216. Neugut AI, Garbowski GC, Lee WC, Murray T, Nieves JW, Forde KA, Treat MR, Waye JD & Fenoglio Preiser C (1993): Dietary risk factors for the incidence and recurrence of colorectal adenomatous polyps: a case-control study. Ann. Intern. Med. 118, 91-95.
217. Newcomb PA, Klein R, Klein BE et al (1995): Association of dietary and life-style factors with sex hormones in postmenopausal women. Epidemiology 6, 318-321.
218. Ng ST, Zhou J, Adesanya OO, Wang J, LeRoith D & Bondy CA (1997): Growth hormone treatment induces mammary gland hyperplasia in aging primates. Nat Med. 3, 1141-1144.
219. Nicklas TA (1995): Dietary studies of children: the Bogalusa Heart Study experience. J. Am. Diet. Assoc. 95, 417-418.
220. Nijpels G (1998): Determinants for the progression from impaired glucose tolerance to non-insulin-dependent diabetes mellitus. Eur. J. Clin. Invest. 28 (Suppl 2), 8-13.
221. Norrish AE, McRae CU, Holdaway IM & Jackson RT (2000): Height-related risk factors for prostate cancer. Br. J. Cancer 82, 241-245.
222. Nuttall FQ, Mooradian AD, Gannon MC, Billington C & Krezowscki P (1984): Effect of protein ingestion on the glucose and insulin response to a standardized oral glucose load. Diabetes Care 7, 465-470.
223. O'Mara BA, Byers T & Schoenfeld E (1985): Diabetes mellitus and cancer risk: a multisite case-control study. J. Chron. Dis. 38, 435-441.
224. O'Riordain MG, Ross JA, Fearon KC, Maingay J, Farouk M, Garden OJ & Carter DC (1995). Insulin and counterregulatory hormones influence acute-phase protein production in human hepatocytes. Am. J. Physiol. 269 (2 Pt 1), E323-330.
225. Orme SM, McNally RJ, Cartwright RA & Belchetz PE (1996): Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J. Clin. Endocrinol. Metab. 83, 2730-2734.
226. Paolisso G, Giugliano D, Pizza G, Gambardella A, Tesauro P, Varricchio M & D'Onofrio F (1992): Glutathione infusion potentiates glucose-induced insulin secretion in aged patients with impaired glucose tolerance. Diabetes Care 15, 1-7.
227. Paolisso G, D'Amore A, Giugliano D et al (1993): Pharmacological doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients. Am. J. Clin. Nutr. 57, 650-656.
228. Paolisso G, D'Amore A, Balbi V et al (1994): Plasma vitamin C affects glucose homeostasis in healthy subjects and non-insulin-dependent diabetics. Am. J. Physiol. 266, E261-E268.
229. Pasquali R, Casimirri F, De Iasio R, Mesini P, Boschi S et al (1995): Insulin regulates testosterone and sex hormone binding-globulin concentrations in adult normal-weight and obese men. J. Clin. Endocrinol. Metab. 80, 654-658.
230. Peters RK, Pike MC, Garabrant D & Mack TM (1992): Diet and colon cancer in Los Angeles County, California. Cancer Causes Control 3, 457-473.
231. Peyrat JP, Bonneterre J, Hecquet B, Vennin P, Louchez MM, Fournier C, Lefebvre J & Demaille A (1993): Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer. Eur. J. Cancer 29A, 492-497.
232. Piatti PM, Monti LD, Pacchioni M, Pontiroli AE & Pozza G (1991). Forearm insulin- and non-insulin-mediated glucose uptake and muscle metabolism in man: role of free fatty acids and blood glucose levels. Metabolism 40, 926-933.
233. Pickle LW, Greene MH, Ziegler RG, Toledo A, Hoover R, Lynch HT & Fraumeni JF Jr (1984): Colorectal cancer in rural Nebraska. Cancer Res. 44, 363-369.
234. Pilichowska M, Kimua N, Fujiwara H & Nagura H (1997): Immunohistochemical study of TGF-α, TGF-β1, EGFR-1 and IGF-1 expression in human breast carcinoma. Mod. Pathol. 10, 969-975.
235. Plymate SR, Matej LA, Jones RE & Friedl KE (1988): Inhibition of sex hormone binding-globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J. Clin. Endocrinol. Metab. 67, 460-464.
236. Plymate SR, Hoop RC, Jones RE & Mtej LA (1990): Regulation of sex hormone-binding globulin production by growth factors. Metabolism 39, 967-970.
237. Polychronakos C, Janthly U, Lehoux JG & Koutsilieris M (1991): Mitogenic effects of insulin and insulin-like growth factors on PA-III rat prostate adenocarcinoma cells: characterization of the receptors involved. Prostate 19, 313-321.
238. Potter JD, Slattery ML, Bostick RM & Gapstur SM (1993): Colon cancer: a review of the epidemiology. Epidemiol. Rev. 15, 499-545.
239. Prewitt TE, Unterman TG, Glick R, Cole TG, Schmeisser D, Bowen PE & Langenberg P (1992): Insulin-like growth factor I and low-density-lipoprotein cholesterol in women during high- and low-fat feeding. Am. J. Clin. Nutr. 55, 381-384.
240. Pyorala K, Savolainen E, Kaukola S & Haapakoski J (1985): Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki policemen study population. Acta. Med. Scand. 701, 38-52.
241. Ragozzino M, Melton LJ III, Chu C-P & Palumbo PJ (1982): Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J. Chron. Dis. 35, 13-19.
242. Rajah R, Valentinis B & Cohen P (1997): Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53 and IGF-1 independent mechanism. J. Biol. Chem. 272, 12181-12188.
243. Rao AV & Agarwal S (1999): Role of lycopene as antioxidant carotenoid in the prevention of chronic diseases: a review. Nutr. Res. 19, 305-323.
244. Rea RL, Thompson LU & Jenkins DJA (1985): Lectins in foods and their relation to starch digestibility. Nutr. Res. 5, 919-929.
245. Reaven GM (1993): Role of insulin resistance in human disease (syndrome X): an expanded definition. A. Rev. Med. 44, 121-131.
246. Remacle-Bonnet MM, Garrouste FL, Heller S, Andre F, Marvaldi JL & Pommier GJ (2000): Insulin-like growth factor-1 protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor alpha-induced mitogen-activated protein kinase and nuclear factor kappaB signaling pathways. Cancer Res. 60, 2007-2017.
247. Renehan AG, Painter JE, Atkin WS, Potten CS, Shalet SM & O'Dwyer ST (2001): High-risk colorectal adenomas and serum insulin-like growth factors. Br. J. Surg. 88, 107-113.
248. Rodin J, Reed D & Jamner L (1988): Metabolic effects of fructose and glucose: implications for food intake. Am. J. Clin. Nutr. 47, 683-689.
249. Rodwell VW, Nordstrom JL & Mitschelen JJ (1976): Regulation of HGM-CoA reductase. Adv. Lipid. Res. 14, 1-76
250. Rohan TE, McMichael AJ & Baghurst PA (1988): A population-based case-control study of diet and breast cancer in Australia. Am. J. Epidemiol. 128, 478-489.
251. Rohan TE, Howe GR, Friedenreich CM et al (1993): Dietary fiber, vitamins A, C, and E, and risk of breast cancer: a cohort study. Cancer Causes Control 4, 29-37.
252. Ron E, Gridley G, Hrubec Z, Page W, Arora S & Fraumeni JF Jr (1992): Acromegaly and gastrointestinal cancer. [Published erratum appears in Cancer 1992; 69: 549.] Cancer 68, 1673-1677.
253. Rossner S (1978): Further studies on serum lipoproteins in connective tissue diseases. Atherosclerosis 31, 93-99.
254. Ruige JB, Assendelft WJ, Dekker JM, Kostense PJ, Heine RJ & Bouter LM (1998): Insulin and risk of cardiovascular disease: a meta-analysis. Circulation 97, 996-1001.
255. Salmeron J, Ascherio, A, Rimm EB et al (1997a): Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care 20, 545-550.
256. Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL & Willett WC (1997b): Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA 277, 472-477.
257. Sanchez-Quesada JL, Perez A, Caixas A, Ordonmez-Llanos J, Carreras G, Payes A, Gonzalez-Sastre F & de Leiva A (1996): Electronegative low density lipoprotein subform is increased in patients with short-duration IDDM and is closely related to glycaemic control. Diabetologia 39, 1469-1476.
258. Sandler RS, Lyles CM, Peipins LA, McAuliffe CA, Woosley JT & Kupper LL (1993): Diet and risk of colorectal adenomas: macronutrients, cholesterol and fiber. J. Natl Cancer Inst. 85, 884-891.
259. Santini SA, Marra G, Giardina B, Cotroneo P, Mordente A, Martorana GE, Manto A & Ghirlanda G (1997): Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes 46, 1853-1858.
260. Sartor O, Cooper MR, Khleif SN & Myers CE (1994): Suramin decreases circulating levels of insulin-like growth factor-1. Am. J. Med. 96, 390.
261. Schafer O (1934): Carcinom und Diabetes (Inaugural Dissertation). Druckerei-Verlag Hans Rosler, Augsburg.
262. Schoen RE, Tangen CM, Kuller LH, Burke GL, Cushman M, Tracy RP, Dobs A & Savage PJ (1999): Increased blood glucose and insulin, body size, and incident colorectal cancer. J. Natl Cancer Inst. 91, 1147-1154.
263. Seely S & Horrobin DF (1983): Diet and breast cancer: the possible connection with sugar consumption. Med. Hypotheses 11, 319-327.
264. Sell C, Rubini M, Rubin R, Liu J-P, Efstratiadis A & Baserga R (1993): Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. Proc. Natl Acad. Sci. USA 90, 11217-11221.
265. Sellers TA, Kushi LH, Potter JD, Kaye SA, Nelson CL, McGovern PG et al (1992): Effect of family history, body-fat distribution, and reproductive factors on the risk of postmenopausal breast cancer. New Engl. J. Med. 326, 1323-1329.
266. Sellers TA, Anderson KE, Olson JE & Folsom AR (1998): Family histories of diabetes mellitus and breast cancer and incidence of postmenopausal breast cancer. Epidemiology 9, 102-105.
267. Severson RK, Nomura AMY, Grove JS & Stemmermann GN (1989): A prospective analysis of physical activity and cancer. Am. J. Epidemiol. 130, 522-529.
268. Sharma A, Kharb S, Chugh SN, Kakkar R & Singh GP (2000): Evaluation of oxidative stress before and after control of glycemia and after vitamin E supplementation in diabetic patients. Metabolism 49, 160-162.
269. Singh A, Hamilton-Fairley D, Koistinen R, Seppala M, James VHT et al (1990): Effects of insulin-like growth factor-type I (IGF-1) and insulin on the secretion of sex hormone-binding globulin and IGF-1 binding protein (IBP-I) by human hepatoma cells. J. Endocrinol. 124, R1-R3.
270. Sites CK, Toth MJ, Cushman M, L'Hommedieu GD, Tchernof A, Tracy RP & Poehlman ET (2002). Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal. Fertil. Steril. 77, 128-135.
271. Skyrme-Jones RA, O'Brien RC, Berry KL & Meredith IT (2000): Vitamin E supplementation improves endothelial function in type I diabetes mellitus: a randomized, placebo-controlled study. J. Am. Coll. Cardiol. 36, 94-102.
272. Slattery ML, Schumacher MC, Smith KR et al (1988): Physical activity, diet and risk of colon cancer in Utah. Am. J. Epidemiol. 128, 989-999.
273. Slattery ML, Benson J, Berry TD, Duncan D, Edwards SL, Caan BJ & Potter JD (1997): Dietary sugar and colon cancer. Cancer Epidemiol. Biomark. Prev. 6, 677-685.
274. Smith GD, Egger M, Shipley MJ & Marmot MG (1992): Post-challenge glucose concentration, impaired glucose tolerance, diabetes and cancer mortality in men. Am. J. Epidemiol. 136, 1110-1114.
275. Stamler J, Vaccaro O, Neaton JD & Wentworth D (1993): Diabetes, other risk factors, and 12-yr cardiovascular mortality in men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16, 434-444.
276. Stampfer MJ, Krauss RM, Ma J et al (1996): A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 276, 882-888.
277. Stampfer MJ, Hu FB, Manson JE, Rimm EB & Willett WC (2000): Primary prevention of coronary heart disease in women through diet and lifestyle. New Engl. J. Med. 343, 16-22.
278. Steenland K, Nowlin S & Palu S (1995): Cancer incidence in the National Health and Nutrition Examination Survey I follow-up data: diabetes, cholesterol, pulse, and physical activity. Cancer Epidemiol. Biomarkers Prev. 4, 807-811.
279. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. (2000): Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Br. Med. J. 321, 405-412.
280. Swanson CA, Jones DY, Schatzkin A, Brinton LA & Ziegler RG (1988): Breast cancer risk assessed by anthropometry in the NHANES I epidemiological follow-up study. Cancer Res. 48, 5363-5367.
281. Talamini R, La Vecchia C, Decarli A, Negri E & Franceschi S (1986): Nutrition, social factors and prostatic cancer in a Northern Italian population. Br. J. Cancer 53, 817-821.
282. Talamini R, Franceschi S, La Vecchia C, Serraino D, Barra S & Negri E (1992): Diet and prostatic cancer: a case-control study in northern Italy. Nutr. Cancer 18, 277-286.
283. Talamini R, Franceschi S, Favero A, Negri E, Parazzini F & La Vecchia C (1997): Selected medical conditions and risk of breast cancer. Br. J. Cancer 75, 1699-1703.
284. Tesfamariam B & Cohen RA (1992): Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am. J. Physiol. 263, H321-326.
285. The Diabetes Control and Complications Trial Research Group (1993): The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl. J. Med. 329, 977-986.
286. Thompson D, Harrison SP, Evans SW & Whicher JT (1991): Insulin modulation of acute-phase protein production in a human hepatoma cell line. Cytokine 3, 619-626.
287. Thompson LU, Yoon JH, Jenkins DJA, Wolever TMS & Jenkins AL (1984): Relationship between polyphenol intake and blood glucose response of normal and diabetic individuals. Am. J. Clin. Nutr. 39, 745-751.
288. Thrasher JB, Tennant MK, Twomey PA, Hansberry KL, Wettlaufer JN & Plymate SR (1996): Immunohistochemical localization of insulin-like growth factor binding proteins 2 and 3 in prostate tissue: clinical correlations. J. Urol. 155, 999-1003.
289. Title LM, Cummings PM, Giddens K & Nassar BA (2000): Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamins C and E. J. Am. Coll. Cardiol. 36, 2185-2191.
290. Toniolo P, Riboli E, Protta F, Charrel M & Cappa AP (1989): Calorie-providing nutrients and risk of breast cancer. J. Natl Cancer Inst. 81, 278-286.
291. Tornberg SA, Holm LE & Carstensen JM (1988): Breast cancer risk in relation to serum cholesterol, serum beta-lipoprotein, height, weight, and blood pressure. Acta Oncol. 27, 31-37.
292. Torring N, Vinter-Jensen L, Pedersen SB, Sorensen FB, Flyvbjerg A & Nexo E (1997): Systemic administration of insulin-like growth factor I (IGF-1) causes growth of the rat prostate. J. Urol. 158, 222-227.
293. Tran TT, Medline A & Bruce RW (1996): Insulin promotion of colon tumors in rats. Cancer Epidemiol. Biomarkers Prev. 5, 1013-1015.
294. Trentham-Dietz A, Newcomb PA, Storer BE et al (1997): Body size and risk of breast cancer. Am. J. Epidemiol. 145, 1011-1019.
295. Tretli S (1989): Height and weight in relation to breast cancer morbidity and mortality: a prospective study of 570,000 women in Norway. Int. J. Cancer 44, 23-30.
296. Trinkler N (1890): Ueber die diagnostische Verwertung des Gehaltes an Zucker und reducirender Substanz im Blute vom Menschen bei verschiedenen Krankheiten. Zbl. Med. Wissen 28, 498-499.
297. Truswell AS (1992): Glycaemic index of foods. Eur. J. Clin. Nutr. 46(Suppl 2), S91-101.
298. Tsai EC, Hirsch IB, Brunzell JD, Chait A (1994): Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes 43, 1010-1014.
299. Tuyns AJ, Haelterman M & Kaaks R (1987): Colorectal cancer and the intake of nutrients: oligosaccharides are a risk factor, fats are not. A case-control study in Belgium. Nutr. Cancer 10, 181-196.
300. Tymchuk CN, Tessler SB, Aronson WJ & Barnard RJ (1998): Effects of diet and exercise on insulin, sex hormone-binding globulin, and prostate-specific antigen. Nutr. Cancer 31, 127-131.
301. UK Prospective Diabetes Study Group (1998): Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDA 33). Lancet 352, 837-852.
302. Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, Le Bon T, Kathuria S & Chen E et al (1986). Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J. 5, 2503-2512.
303. Underwood LE (1996): Nutritional regulation of IGF-1 and IGFBPs. J. Pediat. Edocrinol. Metab. 9, 303-312.
304. van Amelsvoort JM & Weststrate JA (1992): Amylose-amylopectin ratio in a meal affects postprandial variables in male volunteers. Am. J. Clin. Nutr. 55, 712-718.
305. van Dam RM, Visscher AW, Feskens EJ, Verhoef P & Kromhout D (2000): Dietary glycemic index in relation to metabolic risk factors and incidence of coronary heart disease: the Zutphen Elderly Study. Eur. J. Clin. Nutr. 54, 726-731.
306. van den Brandt PA, Dirx MJ, Ronckers CM, van den Hoogen P & Goldbohm RA (1997): Height, weight change, and postmenopausal breast cancer risk: The Netherlands Cohort Study. Cancer Causes Control 8, 39-47.
307. van't Veer P, Kalb CM, Verhoef P et al (1990): Dietary fiber, β-carotene and breast cancer: results from a case-control study. Int. J. Cancer 45, 825-828.
308. Vatten LJ & Kvinnsland S (1990): Body mass index and risk of breast cancer. A prospective study of 23,826 Norwegian women. Int. J. Cancer 45, 440-444.
309. Vatten LJ & Kvinnsland S (1992): Prospective study of height, body mass index and risk of breast cancer. Acta Oncol. 31, 195-200.
310. Vega GL & Grundy SM (1996): Hypoalphalipoproteinemia (low high density lipoprotein) as a risk factor for cornary heart disease. Curr. Opin. Lipid. 7, 209-216.
311. Vena JE, Graham S, Zielezny M et al (1987): Occupational exercise and risk of cancer. Am. J. Clin. Nutr. 45, 318-327.
312. Virkamaki A, Ueki K & Kahn C (1999): Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. Review. J. Clin. Invest. 103, 931-943.
313. Wakai K, Dillon DS, Ohno Y, Prihartono J et al (2000): Fat intake and breast cancer risk in an area where fat intake is low: a case-control study in Indonesia. Int. J. Epidemiol. 29, 20-28.
314. Warren R, Yuan H, Matli M, Ferrara N & Donner D (1996): Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma. J. Biol. Chem. 271 29483-29488
315. Watkins LF, Lewis FR & Levine AE (1990): Characterization of the synergistic effects of insulin and transferrin and the regulation of their receptors on a human colon carcinoma cell line. Int. J. Cancer 45 372-375.
316. Weiderpass E, Gridley G, Nyren O, Ekborn A, Persson I & Adami HO (1997a): Diabetes mellitus and risk of large bowel cancer. J. Natl Cancer Inst. 89, 660-661.
317. Weiderpass E, Gridley G, Persson I, Nyren O, Ekbom A & Adami HO (1997b): Risk of endometrial and breast cancer in patients with diabetes mellitus. Int. J. Cancer 71, 60-63.
318. Welch IM, Bruce C, Hill SE & Read NW (1987): Duodenal and ileal lipid suppresses postprandial blood glucose and insulin responses in man: possible implications for the dietary management of diabetes mellitus. Clin. Sci. (Lond) 72, 209-216.
319. Wideroff L, Gridley G, Mellemkjaer L, Chow WH, Linet M, Keehn S, Borch-Johnsen K & Olsen JH (1997): Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J. Natl Cancer Inst. 89, 1360-1365.
320. Will JC, Galuska DA, Vinicor F & Calle EE (1998): Colorectal cancer: another complication of diabetes mellitus? Am. J. Epidemiol. 147, 816-825.
321. Will JC, Vinicor F & Calle EE (1999): Is diabetes mellitus associated with prostate cancer incidence and survival? Epidemiology 10, 313-318.
322. Williams SB, Cusco JA, Roddy MA, Johnstone MT & Creager MA (1996): Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J. Am. Coll. Cardiol. 27, 567-574.
323. Wolever TMS (1990): The glycemic index. In: Aspects of Some Vitamins, minerals and Enzymes in Health and Disease, ed. GH Borne. World Review Nutrition Diet, Vol. 62, pp 120-185. Basel; Karger.
324. Wolever TMS & Jenkins DJA (1986). The use of the glycemic index in predicting the blood glucose response to mixed meals. Am. J. Clin. Nutr. 43, 167-172.
325. Wolever TMS, Nuttell FQ, Lee R et al (1985): Prediction of the relative blood glucose response of mixed meals using the white bread glycemic index. Diabetes. Care 8, 418-428.
326. Wolever TMS, Brighenti F & Jenkins DJA (1988): Serum short chain fatty acids after rectal infusion of acetate and propionate in man. J. Clin. Nutr. Gastroenterol. 3, 42-49.
327. Wolever TMS, Jenkins DJA, Jenkins AL & Josse RG (1991): The glycemic index: methodology and clinical implications. Am. J. Clin. Nutr. 54, 846-854.
328. Wolever TMS, Jenkins DJA, Vuksan V, Jenkins AL, Wong GS & Josse RG (1992a): Beneficial effect of low-glycemic index diet in overweight NIDDM subjects. Diabetes Care 15, 562-564.
329. Wolever TMS, Jenkins DJA, Vuksan V, Jenkins AL, Buckley GC, Wong GS & Josse RG (1992b): Beneficial effect of a low-glycaemic index diet in type 2 diabetes. Diabetes. Med. 9, 451-458.
330. Wolever TMS, Katzman-Relle L, Jenkins AL, Vuksan V, Josse RG & Jenkins DJA (1994): Glycaemic index of 102 complex carbohydrate foods in patients with diabetes. Nutr. Res. 14, 651-669.
331. Wolever TM, Hamad S, Chiasson JL, Josse RG, Leiter LA, Rodger NW, Ross SA & Ryan EA (1999): Day-to-day consistency in amount and source of carbohydrate associated with improved blood glucose control in type 1 diabetes. J. Am. Coll. Nutr. 18, 242-247.
332. Wolk A, Mantzoros CS, Andersson SO, Bergstrom R, Signorello LB, Lagiou P et al (1998): Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J. Natl Cancer Inst. 90, 911-915.
333. Wright RS, Anderson JW & Bridges SR (1990): Propionate inhibits hepatocyte lipid synthesis. Proc. Soc. Exp. Biol. Med. 195, 26-29.
334. Wynder EL, Kajitani T, Ishikawa S, Dodo H & Takano A (1969): Environmental factors of cancer of the colon and rectum. II. Japanese epidemiological data. Cancer 23, 1210-1220.
335. Yamada K, Araki S, Tamura M, Sakai I, Takahashi Y, Kashihara H & Kono S (1998): Relation of serum total cholesterol, serum triglycerides and fasting plasma glucose to colorectal carcinoma in situ. Int. J. Epidemiol. 27, 794-798.
336. Yee D & Lee AV (2000): Crosstalk between the insulin-like growth factors and estrogens in breast cancer. J. Mammary Gland Biol. Neoplasia 5, 107-115.
337. Yoon JH, Thompson LU & Jenkins DJA (1983) The effect of phytic acid on in vitro rate of starch digestibility and blood glucose response. Am. J. Clin. Nutr. 38, 835-842.
338. Zaridze D, Lifanova Y, Maximovitch D, Day NE & Duffy SW (1991): Diet, alcohol consumption and reproductive factors in a case-control study of breast cancer in Moscow. Int. J. Cancer 48, 493-501.
339. Zaridze D, Filipchenko V, Kustov V et al (1993): Diet and colorectal cancer: results of two case-control studies in Russia. Eur. J. Cancer 29A, 112-115.